Chelsea Therapeutics International LtdCHTP:NAQ

4.73
0.03 / 0.63 %
2.04m
152.27%
1.90
Close in USDToday's changeShares traded1 year changeBeta
As of Apr 17 2014 21:00 BST.Data delayed by at least 15 minutes.

Summary

On Thursday, Chelsea Therapeutics International Ltd (CHTP:NAQ) closed at 4.73, 30.75 % below its 52-week high of 6.83, set on Feb 19, 2014.

52-week range
Today
1.68
Apr 24 2013
6.83
Feb 19 2014
Open4.71
Day high4.88
Day low4.58
Bid--
Offer--
Previous close4.76
Average volume2.40m
Shares outstanding78.43m
Free float73.76m
P/E (TTM)--
Market cap370.99m USD
EPS (TTM)-0.2373 USD

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Chelsea Therapeutics International Ltd-3.86 %-24.20 %+58.19 %+152.27 %+176.61 %
S&P 500 INDEX+2.71 %-0.40 %+6.90 %+20.97 %+114.45 %
USA/HEALTH CARE+2.09 %-4.48 %+7.40 %+16.24 %--
USA/BIOTECHNOLOGY+4.52 %-12.87 %+2.07 %+17.44 %--
As of Apr 17 2014 21:00 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.